LUCENTIS - dosage, use, side effects, indication


 
Genérico: ranibizumab
Substancia activa: Ranibizumab ()
Alternativas: Byooviz, Lucentis, Ranivisio, Ximluci
Grupo ATC: S01LA04 - ranibizumab
Contenido de sustancia activa: 10MG/ML
Formularios: INJ SOL
: VIA
: 1X0,23ML III (INJ SOL)
:
: Agentes de trastornos vasculares oculares
:



Lucentis -

Overview
Side effects
Interactions
Dosage
Prices & alternatives
Package insert
Package insert - complet
Interactions (all)
Side effects (all)
Availability
Effects, indications
Alternatives
Lucentis - Alcohol
Reviews and ratings
Rankings
Comments
Discussion (faq)
Summary of data
Summary of data - package insert (spc)


Copyright © 2018 Pharmacum.eu. All Rights Reserved. (0.06)

Más información